Page last updated: 2024-09-03

ezogabine and Cerebral Infarction, Middle Cerebral Artery

ezogabine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bierbower, SM; Choveau, FS; Lechleiter, JD; Shapiro, MS	1

Other Studies

1 other study(ies) available for ezogabine and Cerebral Infarction, Middle Cerebral Artery

Article	Year
Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Feb-04, Volume: 35, Issue:5 Topics: Animals; Anthracenes; Carbamates; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; KCNQ Potassium Channels; Male; Mice; Mice, Inbred C57BL; Phenylenediamines; Potassium Channel Blockers	2015

Article

Year

Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Feb-04, Volume: 35, Issue:5

Topics: Animals; Anthracenes; Carbamates; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; KCNQ Potassium Channels; Male; Mice; Mice, Inbred C57BL; Phenylenediamines; Potassium Channel Blockers

2015